Wealthstreet Investment Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-115,820	Closed	-$2.99M	–	98
2021 Q1	$2.99M	Sell	115,820 -28,900	-20%	-$1.27M	0.29%	80
2020 Q4	$7.74M	Sell	144,720 -1,900	-1%	-$94.3K	0.78%	30
2020 Q3	$6.05M	Buy	146,620 +2,250	+2%	+$97.2K	0.68%	36
2020 Q2	$7M	Sell	144,370 -3,200	-2%	-$154K	0.86%	31
2020 Q1	$6.24M	Buy	147,570 +100	+0.1%	+$4.12K	0.92%	30
2019 Q4	$6.31M	Sell	147,470 -170	-0.1%	-$7.4K	0.74%	38
2019 Q3	$6.24M	Sell	147,640 -8,640	-6%	-$262K	0.8%	37
2019 Q2	$4.18M	Sell	156,280 -3,050	-2%	-$77.9K	0.54%	53
2019 Q1	$4.28M	Buy	159,330 +4,000	+3%	+$93.4K	0.56%	51
2018 Q4	$3.43M	Sell	155,330 -28,500	-16%	-$553K	0.48%	57
2018 Q3	$3.82M	Sell	183,830 -680	-0.4%	-$10.7K	0.47%	57
2018 Q2	$2.82M	Sell	184,510 -25,880	-12%	-$461K	0.37%	70
2018 Q1	$4.73M	Buy	210,390 +9,930	+5%	+$275K	0.59%	42
2017 Q4	$6.04M	Buy	+200,460	New	+$6.41M	0.73%	31